Krisztina Vukics

Nitrone derivatives of trolox as neuroprotective agents.

A. Gere, G. Balogh, J. Fischer, 2005, Bioorganic & medicinal chemistry letters.

Chemical and biological investigation of cyclopropyl containing diaryl-pyrazole-3-carboxamides as novel and potent cannabinoid type 1 receptor antagonists.

B. Kiss, Péter Erdélyi, J. Fischer, 2009, Journal of medicinal chemistry.

Identification of Triazolopyridines as Selective α5-GABAA Receptor Negative Allosteric Modulators by a Hybridization Approach.

A. Bobok, Attila Potor, M. Vastag, 2022, ACS chemical neuroscience.

Hit-to-lead optimization of pyrrolo[1,2-a]quinoxalines as novel cannabinoid type 1 receptor antagonists.

R. Kiss, L. Molnár, G. Keserű, 2009, Bioorganic & medicinal chemistry letters.

Structure of the major degradant of ezetimibe.

C. Szántay, J. Kóti, Krisztina Vukics, 2012, Journal of pharmaceutical and biomedical analysis.

Improved industrial synthesis of antidepressant sertraline

J. Fischer, T. Fodor, Krisztina Vukics, 2002 .

Development of Dual V1a/V2 Antagonists Containing Triazolobenzazepine Scaffold

F. Baska, I. Magdó, M. Vastag, 2024, European Journal of Medicinal Chemistry.

Discovery and Characterization of RGH-122, a Potent, Selective, and Orally Bioavailable V1a Receptor Antagonist.

F. Baska, Dalma Kurkó, I. Greiner, 2024, Journal of medicinal chemistry.